The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted

被引:20
作者
Capitanio, Umberto [1 ,3 ]
Karakiewicz, Pierre I. [1 ,2 ]
Jeldres, Claudio [1 ,2 ]
Briganti, Alberto [3 ]
Gallina, Andrea [3 ]
Suardi, Nazareno [3 ]
Cestari, Andrea [3 ]
Guazzoni, Giorgio [3 ]
Salonia, Andrea [3 ]
Montorsi, Francesco [3 ]
机构
[1] Univ Montreal, Ctr Hlth, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ H2X 3J4, Canada
[2] Univ Montreal, Dept Urol, Montreal, PQ, Canada
[3] Vita Salute San Raffaele, Dept Urol, Milan, Italy
关键词
decision-making; Gleason score upgrading; nomogram; radical prostatectomy; ACTIVE SURVEILLANCE; CLINICAL PREDICTORS; PATHOLOGICAL STAGE; CANCER; RADIOTHERAPY; NOMOGRAM; RECURRENCE; IMPROVES; SUM;
D O I
10.1111/j.1442-2042.2009.02270.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
The objective of this study was to test the external validity of a previously developed nomogram for the prediction of Gleason score upgrading (GSU) between biopsy and radical prostatectomy (RP). The study population consisted of 973 assessable patients treated with RP at a tertiary care institution. The accuracy of the nomogram was quantified with the receiver operating characteristics curve-derived area under the curve. The performance characteristics (predicted vs observed rate of GSU) were tested within a calibration plot. Overall, GSU was recorded in 39.8% (n = 387) of patients at RP. Of patients with GSU, 70 (18.1%), 23 (5.9%) and 32 (8.3%), respectively, had extracapsular extension, seminal vesicle invasion and lymph node invasion. The accuracy of the nomogram was 74.9% (confidence interval 72.1-77.6%). The model tended to underestimate the observed rate of GSU and the discordance between the predicted and observed rate of GSU ranged from -7 to +10%. The current tool represents the most accurate method of predicting GSU between biopsy and RP. Nonetheless it is not perfect and its performance characteristics should be known prior to its use in clinical decision-making.
引用
收藏
页码:526 / 529
页数:4
相关论文
共 26 条
[1]
Does radical prostatectomy provide a survival benefit as primary treatment for high-grade prostate cancer? [J].
Albertsen, Peter C. .
NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (02) :68-69
[2]
Open radical retropubic prostatectomy [J].
Barre, Christian .
EUROPEAN UROLOGY, 2007, 52 (01) :71-80
[3]
Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival [J].
Bastian, Patrick J. ;
Hutterer, Georg C. ;
Shariat, Shahrokh F. ;
Rogers, Craig G. ;
Palapattu, Ganesh S. ;
Lotan, Yair ;
Vazina, Amnon ;
Amiel, Gilad E. ;
Gupta, Amit ;
Sagalowsky, Arthur I. ;
Lerner, Seth P. ;
Schoenberg, Mark P. ;
Karakiewicz, Pierre I. .
BJU INTERNATIONAL, 2008, 101 (04) :450-454
[4]
Re:: Felix K-H.!Chun, Thomas!Steuber, andreas erbersdobler, et al. development and internal validation of a nomogram predicting the probability of prostate cancer gleason sum upgrading between biopsy and radical prostatectomy pathology.: Eur Urol 2006;49:820-26 [J].
Beckley, Ian ;
Khan, Masood A. .
EUROPEAN UROLOGY, 2007, 52 (04) :1270-1270
[5]
First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer [J].
Blana, Andreas ;
Murat, Francois J. ;
Walter, Bernhard ;
Thuroff, Stefan ;
Wieland, Wolf F. ;
Chaussy, Christian ;
Gelet, Albert .
EUROPEAN UROLOGY, 2008, 53 (06) :1194-1203
[6]
The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 Gy to treat prostate cancer:: In regard to Eade et al. (Int J Radiat Oncol Biol Phys 2007;68:682-689) [J].
Cheung, M. Rex .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (02) :645-645
[7]
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium [J].
Chun, Felix K. -H. ;
Briganti, Alberto ;
Gallina, Andrea ;
Hutterer, Georg C. ;
Shariat, Shahrokh F. ;
Antebie, Elie ;
Walz, Jochen ;
Roehrborn, Claus G. ;
Salonia, Andrea ;
Rigatti, Patrizio ;
Saad, Fred ;
Huland, Hartwig ;
Montotsi, Francesco ;
Graefen, Markus ;
Karakiewicz, Pierre I. .
EUROPEAN UROLOGY, 2007, 52 (04) :1067-1075
[8]
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology [J].
Chun, FKH ;
Steuber, T ;
Erbersdobler, A ;
Currlin, E ;
Walz, J ;
Schlomm, T ;
Haese, A ;
Heinzer, H ;
McCormack, M ;
Huland, H ;
Graefen, M ;
Karakiewicz, PI .
EUROPEAN UROLOGY, 2006, 49 (05) :820-826
[9]
Clinical predictors of upgrading to gleason grade 4 or 5 disease at radical prostatectomy: Potential implications for patient selection for radiation and androgen suppression therapy [J].
D'Amico, AV ;
Renshaw, AA ;
Arsenault, L ;
Schultz, D ;
Richie, JP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (04) :841-846
[10]
Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: The jury is still out [J].
DAmico, AV ;
Coleman, CN .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :304-315